The gene patent controversy on Twitter: A case study of Twitter users' responses to the CHEO lawsuit against Long QT gene patents

BMC Medical Ethics

Volumn 16, Issue 1, 2015, Pages

  Du, Li ^a   Kamenova, Kalina ^b   Caulfield, Timothy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b TRENT UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; CANADA; CHILD; ETHICS; GENE; GENETIC SCREENING; GENETICS; HEALTH CARE DELIVERY; HOSPITAL; HUMAN; INTERNET; INTERPERSONAL COMMUNICATION; JURISPRUDENCE; LEGISLATION AND JURISPRUDENCE; LONG QT SYNDROME; ONTARIO; PATENT; PATIENT RIGHT; SOCIAL MEDIA;

ATTITUDE TO HEALTH; CANADA; CHILD; COMMUNICATION; GENES; GENETIC TESTING; HEALTH SERVICES ACCESSIBILITY; HOSPITALS; HUMANS; INTERNET; JURISPRUDENCE; LONG QT SYNDROME; ONTARIO; PATENTS AS TOPIC; PATIENT RIGHTS; SOCIAL MEDIA;

EID: 84940207305     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/s12910-015-0049-1     Document Type: Article

References (29)

1. Scanfeld D, Scanfeld V, Larson LE. Dissemination of health information through social networks: Twitter and antibiotics. Am J Infect Control. 2010;38(3):182-8.
2. Twitter. Twitter usage. 2015. https://about.twitter.com/company. Accessed 20 Jun 2015.
3. King D, Ranurez-Cano D, Greaves F, Vlaev I, Beales S, Darzi A. Twitter and the health reforms in the English National Health Service. Health Policy. 2013;110(2-1):291-7.
4. Greaves F, Ramirez-Cano D, Millett C, Darzi A, Donaldson L. Harnessing the cloud of patient experience: using social media to detect poor quality healthcare. BMJ Qual Saf. 2013;22:251-5.
5. Reavley NJ, Pilington PD. Use of Twitter to monitor attitudes toward depression and schizophrenia: an exploratory study. PeerJ. 2014;2, e647.
6. Centola D, van de Rijt A. Choosing your network: social preferences in an online health community. Soc Sci Med. 2015;125:19-31.
7. Haustein S, Peters I, Sugimoto CR, Thelwall M, Larivière V. Tweeting biomedicine: an analysis of tweets and citations in the biomedical literature. J Assoc Inform Sci Technol. 2013;65(4):656-69.
8. Signorini A, Segre AM, Polgreen PM. The use of twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. Plos One. 2011;6(5), e19467.
9. Chou W-YS, Hunt YM, Beckjord EB, Moser RP, Hesse BW. Social media use in the United States: implications for health communication. J Med Internet Res. 2009;11(4), e48.
10. Robillard JM, Whiteley L, Johnson TW, Lim J, Wasserman WW, Illes J. Utilizing social media to study information-seeking and ethical issues in gene therapy. J Med Internet Res. 2013;15(3), e44.
11. Liddicoat J, Whittton T, Nicol D. Are the gene-patent storm clods dissipating? A global snapshot. Nat Biotechnol. 2015;33:347-52.
12. Russo AH. Association for Molecular Pathology v. Myriad genetics. Inc. and its impact on the patentability of "Designer" genes. NYU J Intell Pro Ent L. 2014;4(1):37-66.
13. Joly Y, Tonin PN. Social, ethical and legal considerations raised by the discovery and patenting of the BRCA1 and BRCA2. N Genet Soc. 2014;33(2):167-80.
14. CBC News. U.S. Gene patents: patient care stymied in Canada, hospital claims November 03, 2014. http://www.cbc.ca/news/health/u-s-gene-patents-patient-care-stymied-in-canada-hospital-claims-1.2820211. Accessed June 20, 2015.
15. Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, et al. Genetic testing in the Long QT Syndrome development and validation of an efficient approach to genotyping in clinical practice. JAMA. 2005;294(23):2975-80.
16. CTV News. Ontario Hospital launches lawsuit against owners of gene patent, November 03, 2014. http://www.ctvnews.ca/health/ontario-hospital-launches-lawsuit-against-owners-of-gene-patent-1.2084144. Accessed June 20, 2015.
17. Glatter K. Genetic testing for Long QT Syndrome - Is it a useful tool?. 2009. http://www.eplabdigest.com/articles/Genetic-Testing-Long-QT-Syndrome-%E2%80%94-Is-it-a-Useful-Tool. Accessed June 23, 2015.
18. 5 things to know about the Canadian gene patent case, November 03, 2014. http://www.ourwindsor.ca/news-story/4958499-5-things-to-know-about-the-canadian-gene-patent-case/. Accessed June 20, 2015.
19. Caulfield T, Knoppers BM, Gold R, Sheremeta LE, Bridge PJ. Genetic technologies, health care policy and the patent bargain. Clin Genet. 2002;63(1):15-8.
20. Khan BZ. Trolls and other patent inventions: economic history and the patent controversy in the twenty-first century. Geo Mason L Rev. 2014;21:825-63.
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74.
22. CTV News. CHEO launches lawsuit against owners of gene patent, November 03, 2014. http://ottawa.ctvnews.ca/cheo-launches-lawsuit-against-owners-of-gene-patent-1.2084430. Accessed June 20, 2015.
23. Dyer O. Canadian Hospital seeks to end patenting of human genes. BMJ. 2014;349:g6732.
24. Caulfield T, Bubela T, Murdoch CJ. Myriad and the mass media: the covering of a gene patent controversy. Genet Med. 2007;9(12):850-5.
25. Caulfield T, Einsiedel E, Merz JF, Nicol D. Trust, patents and public perceptions: the governance of controversial biotechnology research. Nat Biotechnol. 2006;24:1352-54.
26. Abraham S, Castle D, Gold R. How a gene-patent test case will help both patients and inventors, November 4, 2014. http://www.theglobeandmail.com/globe-debate/how-a-gene-patent-test-case-will-help-both-patients-and-inventors/article21437174/. Accessed June20, 2015.
27. Chandrasekharan S, McGuire AL, Van den Veyver IB. Do resent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? Prenat Diagn. 2014;34(10):921-6.
28. Ksselheim AS, Cook-Deegan RM, Winickoff DE, Mello MM. Gene patenting - the Supreme Court finally speaks. N Engl J Med. 2013;369(9):869-75.
29. Canadian Organization for rare disorders. http://www.raredisorders.ca/?. Assessed June 28, 2015.